|
||||||||||||||||||||||
Speedel (SWX: SPPN) is a biopharmaceutical company that seeks to create value for patients, partners and investors by developing innovative therapies for cardiovascular and metabolic diseases. Speedel is a world leader in renin inhibition, a promising new approach with significant potential for treating cardiovascular diseases. |
||||||||||||||||||||||
|
||||||||||||||||||||||
